Professor of Medicine; Microbiology, NYMC
Allergy & Immunology
Dr. Raymond J. Dattwyler, MD
|
|
Give Review
Dr. Raymond J. Dattwyler practices Allergy & Immunology. He researched medicine at University at Buffalo, School of Medicine and Biomedical Sciences. He received awards:"Best Doctors in America", "New York Mag. Best Doctors in New York", "NIH Postdoctoral Fellowship", "Clara A. March Scholarship", "NIH Predoctoral Fellowship", "Fellow (FAAAAI)", "Super Doctor" and "Top MD". Raymond J. Dattwyler is also a published doctor. He has 92 paper published. The most recent paper is: [Cardiac manifestations of Lyme borreliosis with special reference to contractile dysfunction]. Raymond J. Dattwyler accepts all Medicare patients.
Publications
- Decorin binding proteins a and B in the serodiagnosis of lyme disease in north america.
- Comparison of Lyme disease serologic assays and "Lyme specialty laboratories"
- Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease.
- Treatment trials for post-lyme disease symptoms revisited.
- An outer surface protein C (OspC) peptide derived from Borrelia burgdorferi sensu strico as a target for the serodiagnosis of early Lyme disease.
- Inhibition of sensitization of T-cells by alpha-fetoprotein.
- Immunosuppression by alpha-fetoprotein.
- Prednisone and beclomethasone for treatment of Asthma.
- Pneumomediastinum as a complication of Asthma in teenage and young adult patients.
- Mapping the major antigenic domains of the native flagellar antigen of Borrelia burgdorferi.
- Borrelia burgdorferi HSP70 homolog: characterization of an immunoreactive stress protein.
- The 93-kilodalton protein of Borrelia burgdorferi: an immunodominant protoplasmic cylinder antigen.
- Complications of Lyme borreliosis.
- Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection.
- Cross-antigenicity between the major surface proteins (ospA and ospB) and other proteins of Borrelia burgdorferi.
- Controlled prospective study of factor IX concentrate therapy and immunoDeficiency.
- Inverted T helper/T suppressor lymphocyte ratio is not a reliable indicator of coexistent HIV infection in the presence of carcinoma: report of a patient with ovarian ...
- Lyme neuroborreliosis: central nervous system manifestations.
- Treatment of Lyme borreliosis.
- Lyme borreliosis.
- Immunologic aspects of Lyme borreliosis.
- A perspective on the treatment of Lyme borreliosis.
- Immunodiagnosis of Lyme borreliosis.
- Antibiotic treatment of Lyme borreliosis.
- Carpal tunnel syndrome in Lyme borreliosis.
- Biochemical and immunological characterization of the surface proteins of Borrelia burgdorferi.
- Treatment of late Lyme borreliosis--randomised comparison of ceftriaxone and penicillin.
- Lymphocyte subsets in women on low dose oral contraceptives.
- Cellular Immune response in Lyme disease: the response to mitogens, live Borrelia burgdorferi, NK cell function and lymphocyte subsets.
- [Cardiac manifestations of Lyme borreliosis with special reference to contractile dysfunction].
- Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans.
- A rapid test for detection of Lyme disease antibodies.
- Infection with multiple strains of Borrelia burgdorferi sensu stricto in patients with Lyme disease.
- Recombinant chimeric Borrelia proteins for diagnosis of Lyme disease.
- Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America.
- A first-tier rapid assay for the serodiagnosis of Borrelia burgdorferi infection.
- New chemotherapeutic approaches in the treatment of Lyme borreliosis.
- Nervous system abnormalities in Lyme disease.
- Specific Immune responses in Lyme borreliosis. Characterization of T cell and B cell responses to Borrelia burgdorferi.
- Antigen-specific T-cell anergy in progressive Mycobacterium marinum infection in humans.
- Ceftriaxone as effective therapy in refractory Lyme disease.
- Failure of tetracycline therapy in early Lyme disease.
- Mycobacterium marinum infections of the hand.
- Lyme meningoencephalitis: report of a severe, penicillin-resistant case.
- Lyme disease: cause of a treatable peripheral neuropathy.
- Synthesis of C1 inhibitor (C1-INA) by a human monocyte-like cell line, U937.
- Cross-reactive antigenic domains of the flagellin protein of Borrelia burgdorferi.
- Borrelia burgdorferi is clonal: implications for taxonomy and vaccine development.
- Occurrence of antibodies to Borrelia burgdorferi in patients with nonspirochetal subacute bacterial endocarditis.
- Purification of Borrelia burgdorferi outer surface protein A (OspA) and analysis of antibody binding domains.
- Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial.
- Clarithromycin in treatment of early Lyme disease: a pilot study.
- Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease.
- A critical appraisal of "chronic Lyme disease".
- Ceftriaxone--An effective treatment of late Lyme borreliosis.
- Recombinant assay for serodiagnosis of Lyme disease regardless of OspA vaccination status.
- IgE antithyroid antibodies in patients with Hashimoto's disease and chronic urticaria.
- LcrV capture enzyme-linked immunosorbent assay for detection of Yersinia pestis from human samples.
- A comparison of two treatment regimens of ceftriaxone in late Lyme disease.
- Community-acquired pneumonia in the age of bio-terrorism.
- Oral vaccine that breaks the transmission cycle of the Lyme disease spirochete can be delivered via bait.
- Response to meta-analysis of Lyme borreliosis symptoms.
- The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Dis...
- Single-dose prophylaxis against Lyme disease.
- Epitope length, genospecies dependency, and serum panel effect in the IR6 enzyme-linked immunosorbent assay for detection of antibodies to Borrelia burgdorferi.
- IFNgamma production in peripheral blood of early Lyme disease patients to hLFAalphaL (aa326-345).
- Anti-tumor necrosis factor-alpha activation of Borrelia burgdorferi spirochetes in antibiotic-treated murine Lyme borreliosis: an unproven conclusion.
- A commentary on the treatment of early lyme disease.
- Platform technology to deliver prophylactic molecules orally: an example using the Class A select agent Yersinia pestis.
- Scientific evidence and best patient care practices should guide the ethics of Lyme disease activism.
- Antiscience and ethical concerns associated with advocacy of Lyme disease.
- Oral immunization with recombinant lactobacillus plantarum induces a protective Immune response in mice with Lyme disease.
- Analysis of a flawed double-blind, placebo-controlled, clinical trial of patients claimed to have persistent Lyme disease following treatment.
- Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial.
- Single-dose doxycycline for the prevention of Lyme disease.
- Improved serodiagnostic testing for Lyme disease: results of a multicenter serologic evaluation.
- Neurologic manifestations in children with North American Lyme disease.
- Modulation of natural killer cell activity by Borrelia burgdorferi.
- Simultaneous expression of Borrelia OspA and OspC and IgM response in cerebrospinal fluid in early neurologic Lyme disease.
- Spirochetal infection of the central nervous system.
- Ventricular tachycardia associated with Lyme carditis.
- Diagnostic tests in Lyme borreliosis.
- Lymphocyte subsets in the neonates of preeclamptic mothers.
- Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi.
- Amoxycillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis.
- Immunologic and structural characterization of the dominant 66- to 73-kDa antigens of Borrelia burgdorferi.
- Mapping antibody-binding domains of the major outer surface membrane protein (OspA) of Borrelia burgdorferi.
- Lyme neuroborreliosis. Peripheral nervous system manifestations.
- Spirochetal arthritis, including Lyme disease.
- Positive Lyme serology in subacute bacterial endocarditis. A study of four patients.
- Binding of alpha-foetoprotein to murine T cells.
Schools
University At Buffalo State University Of New York School Of Medicine
Wisc University Hospital
Tufts New England Med Center
Harvard Mass Genl Hospital
Mayo Clinic Rochester
Hofstra University
Procedures Preformed
- Allergy Shots
- Drug or Food Challenge
Conditions Treated
- Allergic Rhinitis
- Angioedema
- Animal Allergies
- Asthma
- View All
Doctors Specialties
- Allergy
- Immunology
Accepted Insurances
Awards
- Best Doctors in America
- New York Mag. Best Doctors in New York
- NIH Postdoctoral Fellowship
- Clara A. March Scholarship
- NIH Predoctoral Fellowship
- Fellow (FAAAAI)
- Super Doctor
- Top MD
Education
-
Massachusetts General Hospital -
Tufts Medical Center -
University of Wisconsin -
University at Buffalo, School of Medicine and Biomedical Sciences
Hospital
-
Mount Sinai Hospital
Drug Facts
| NPI NUMBER | 1285658989 | |
| NPPES Provider LastName | DATTWYLER | |
| NPPES Provider FirstName | RAYMOND | |
| NPPES Provider ZIPCode | 106052217 | |
| NPPES Provider State | NY | |
| Specialty Description | Allergy/Immunology | |
| Total Claim Count | 104.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1285658989 |
| Last Name Of The Provider | DATTWYLER |
| First Name Of The Provider | RAYMOND |
| View All |
Similar Doctors
|
|
Dr. Kirk E. Sperber, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shari L. Klig, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ilene J. Goldstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul B. Lang, MD
This Doctor is OpenDoctor Recommended.
|